TAE Life Sciences is sponsoring an Industry-Expert Theater Session at #ASTRO21: attendees will hear presentations from @MayoClinic’s Timothy Malouff, @Fond_CNAO’s Ester Orlandi & @taelifesciences' Kendall Morrison about clinical applications & technical advancements in BNCT.
Hear our CEO Bruce Bauer's interview with ITN Online describing the new era of #BNCT for biologically-targeted radiation therapy and the hope it brings patients with difficult to treat #Cancers. https://t.co/CqJV3DcoLt
#radonc#CancerResearch#cancertreatment
Are you interested in finding out more about biologically targeted radiation therapy and how it can improve survival in patients with difficult to treat cancers?
Check out our new video:
https://t.co/NqQqFHU0fv
#BNCT#radonc#targetedtherapy#cancerresearch
“Small world” (#414) now showing at the #deyoungmuseum#deyoungopen from Oct 10 - Jan 3, 2021. So proud of my amazing husband. You did it! ❤️🍾 https://t.co/4MzIMjYdzp
Boron Neutron Capture Therapy (BNCT) has been used in gliomas since the 1950’s, with disappointing results. New advances in imaging and nuclear technologies have overcome previous limitations, giving a second wind to this therapy. Full text: https://t.co/9jEvQsbl23
Dosimetric comparison of Boron Neutron Capture Therapy, Proton Therapy and Volumetric Modulated Arc Therapy for Recurrent Anaplastic #Meningioma. This study demonstrates the dosimetric superiority of #BNCT over #protontherapy and #VMAT. #aeprot#particletherapy
An increase in deaths from breast and colorectal cancers is likely because of delays and diagnosis and treatments. Ignoring cancer care now may trade one public health crisis — Covid-19 — for another, NCI chief... https://t.co/p8UQyU4cga via @statnews#radonc#medonc#cancer
Check out the independent article on our commitment to enabling a new generation of targeted radiation therapy.
$30M for Cancer-Focused TAE Life Sciences | Orange County Business Journal: https://t.co/IqSF1Ct1RJ
#BNCT#radonc#CancerResearch#cancer@TAE
Excited to be included in the @Applied_RadOnc Technology Trends June issue. The new era of BNCT is gaining momentum including the world's first approval of this unique therapy in Japan for the treatment of head and neck cancer patients !
#BNCT#CancerResearch
Congrats to @biocom member @taelifesciences!
"TAE Life Sciences Secures $30M in Initial B Round Phase to Accelerate Development of Unique Boron Delivery Drugs for Novel Cancer Treatment"- https://t.co/KXWEdj9khE
#drugdevelopment#CancerResearch#funding
The first patient treated with BNCT for head and neck cancer. Now covered by insurance in Japan bringing hope for patients with recurrence and limited treatment options! #Cancer#radonc#BNCT#oncology#radiotherapy#medonc
https://t.co/SPbESkqgun